 | |
Acknowledgement:
The research leading to these
results has received support from the Innovative Medicines Initiative Joint Undertaking
under grant agreement n° 115156,
resources of which are composed of financial contribution from the European
Union's Seventh Framework Programme
(FP7/2007-2013) and EFPIA companies’ in kind contribution. The DDMoRe project
is also financially supported by contributions
from Academic and SME partners.
Last modified on 9 February 2017